- Home
- CADL vs OSUR Comparison
CADL vs OSUR Comparison
Compare CADL & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- OSUR
- Stock Information
- Founded
- CADL 1999
- OSUR 2000
- Country
- CADL United States
- OSUR United States
- Employees
- CADL N/A
- OSUR N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- CADL Health Care
- OSUR Health Care
- Exchange
- CADL Nasdaq
- OSUR Nasdaq
- Market Cap
- CADL 234.8M
- OSUR 223.0M
- IPO Year
- CADL 2021
- OSUR 1986
- Fundamental
- Price
- CADL $4.81
- OSUR $2.51
- Analyst Decision
- CADL Strong Buy
- OSUR Hold
- Analyst Count
- CADL 4
- OSUR 2
- Target Price
- CADL $21.00
- OSUR $5.50
- AVG Volume (30 Days)
- CADL 843.6K
- OSUR 435.3K
- Earning Date
- CADL 05-20-2025
- OSUR 05-07-2025
- Dividend Yield
- CADL N/A
- OSUR N/A
- EPS Growth
- CADL N/A
- OSUR N/A
- EPS
- CADL N/A
- OSUR N/A
- Revenue
- CADL N/A
- OSUR $161,626,000.00
- Revenue This Year
- CADL N/A
- OSUR N/A
- Revenue Next Year
- CADL N/A
- OSUR $7.55
- P/E Ratio
- CADL N/A
- OSUR N/A
- Revenue Growth
- CADL N/A
- OSUR N/A
- 52 Week Low
- CADL $3.79
- OSUR $2.69
- 52 Week High
- CADL $14.60
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- CADL 42.39
- OSUR 27.71
- Support Level
- CADL $4.34
- OSUR $2.42
- Resistance Level
- CADL $5.34
- OSUR $3.09
- Average True Range (ATR)
- CADL 0.33
- OSUR 0.11
- MACD
- CADL 0.10
- OSUR -0.03
- Stochastic Oscillator
- CADL 47.11
- OSUR 13.24
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.